Sheltagen Medical

About

Sheltagen Medical develops human bone tissue for implantation in patients with bone fractures or spinal instability. The product is patient specific, using the patients own bone cells and blood components so that the transplant will not be rejected by the patients body. Sheltagen Medicals methodology for bone production in the laboratory involves autologous bone cells seeded on inorganic matrix, cultured in media containing self-blood serum, and exposed to mechanical stimulation by vibration.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Sheltagen Medical's primary focus?

Sheltagen Medical develops human bone tissue for implantation in patients with bone fractures or spinal instability, utilizing patient-specific autologous bone grafts.

Where is Sheltagen Medical headquartered?

Sheltagen Medical is headquartered in Atlit, Center District, Israel.

When was Sheltagen Medical founded?

Sheltagen Medical was founded in December 2009.

What is Sheltagen Medical's current funding stage?

Sheltagen Medical is currently in the Pre-Funding stage.

How many employees does Sheltagen Medical have?

Sheltagen Medical has 6 employees.

What is the core methodology used by Sheltagen Medical for bone production?

Sheltagen Medical's methodology involves culturing autologous bone cells seeded on an inorganic matrix in a self-blood serum medium, exposed to mechanical stimulation by vibration.

Does Sheltagen Medical hold any patents?

Yes, Sheltagen Medical holds 1 patent.

What is Sheltagen Medical's product stage?

Sheltagen Medical's product is in the R&D stage.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyBiomaterials & Tissue Engineering

Technologies

Materials & SubstancesImplants

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Sheltagen Medical — Full Company Profile (machine-readable)

Autologous Bone Graft for Orthopedic and Dental Surgery

About

Facts

Name	Sheltagen Medical
Slug	sheltagen-medical
Type	Israeli Startup
Founded	2009
HQ city	Atlit
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Website	https://www.sheltagen.com
Crunchbase ID	sheltagen-medical
Israeli Companies Registrar	514360981

Team (1)

Name	Role	LinkedIn
Nahum Rosenberg

Intelligence Q&A

What is Sheltagen Medical's primary focus?

Sheltagen Medical develops human bone tissue for implantation in patients with bone fractures or spinal instability, utilizing patient-specific autologous bone grafts.

Where is Sheltagen Medical headquartered?

Sheltagen Medical is headquartered in Atlit, Center District, Israel.

When was Sheltagen Medical founded?

Sheltagen Medical was founded in December 2009.

What is Sheltagen Medical's current funding stage?

Sheltagen Medical is currently in the Pre-Funding stage.

How many employees does Sheltagen Medical have?

Sheltagen Medical has 6 employees.

What is the core methodology used by Sheltagen Medical for bone production?

Sheltagen Medical's methodology involves culturing autologous bone cells seeded on an inorganic matrix in a self-blood serum medium, exposed to mechanical stimulation by vibration.

Does Sheltagen Medical hold any patents?

Yes, Sheltagen Medical holds 1 patent.

What is Sheltagen Medical's product stage?

Sheltagen Medical's product is in the R&D stage.

About

Company Intelligence Q&A

Sectors & technology

Highlights

Tags